Alerts will be sent to your verified email
Verify Email
AMRAPLIN
|
Amrapali Industries
|
Biogen Pharmachem
|
Cerebra Integ. Tech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.68 % | 0.21 % | -1.34 % |
|
5yr Avg Net Profit Margin
|
0.0 | -19.83 % | -13.9 % |
|
Price to Book
|
2.45 | 0.87 | 0.49 |
|
P/E
|
45.79 | 66.23 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.2 Days | 0.0 | 765.04 Days |
|
5yr Average Interest Coverage Ratio
|
1.17 | 902.8 | 1.54 |
|
5yr Avg ROCE
|
21.59 % | 0.21 % | 3.66 % |
|
5yr Avg Operating Profit Margin
|
0.02 % | -19.88 % | -2.53 % |
|
5 yr average Debt to Equity
|
2.08 | 0.0 | 0.11 |
|
5yr CAGR Net Profit
|
14.37 % | n/a | n/a |
|
5yr Average Return on Assets
|
0.61 % | 0.21 % | -0.8 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.43 % | 0.0 | 0.84 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -4.21 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Amrapali Industries
|
Biogen Pharmachem
|
Cerebra Integ. Tech
|
|---|